These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35689315)

  • 1. Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic-authors' reply.
    Hadi Y; Kochhar GS
    Aliment Pharmacol Ther; 2022 Jul; 56(1):178. PubMed ID: 35689315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic.
    Yuan WQ; Li F; Yang LC; Yang ZL; Cui DJ
    Aliment Pharmacol Ther; 2022 Jun; 55(11):1464-1465. PubMed ID: 35538353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply.
    Deputy M; Hart A; Faiz O
    Aliment Pharmacol Ther; 2022 Apr; 55(8):1064. PubMed ID: 35362132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: association between COVID-19 and inflammatory bowel disease-Authors' reply.
    Hadi Y; Kochhar GS
    Aliment Pharmacol Ther; 2022 May; 55(9):1228-1229. PubMed ID: 35429037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply.
    Al-Ani AH; Rentsch CA; Azim S; Bidgood E; Onasseril P; Christensen B
    Aliment Pharmacol Ther; 2020 Aug; 52(4):746-747. PubMed ID: 32886366
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.
    King DS; Trudgill NJ; Adderley NJ
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1442-1443. PubMed ID: 32406090
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply.
    Taxonera C; Alba C
    Aliment Pharmacol Ther; 2020 Aug; 52(4):719-720. PubMed ID: 32886376
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of COVID-19 in patients with IBD - Authors' reply.
    Ding NS; An P; Dong W; Ding Y
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):640-641. PubMed ID: 32553142
    [No Abstract]   [Full Text] [Related]  

  • 9. Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Parekh R; Zhang X; Ungaro RC; Brenner EJ; Agrawal M; Colombel JF; Kappelman MD
    Dig Dis Sci; 2022 Apr; 67(4):1271-1277. PubMed ID: 34181165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply.
    Bhurwal A; Mutneja H; Seril D
    Aliment Pharmacol Ther; 2022 Jul; 56(1):164-165. PubMed ID: 35689313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply.
    Kokkotis G; Kitsou K; Bamias G
    Aliment Pharmacol Ther; 2022 May; 55(9):1235-1236. PubMed ID: 35429035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotional state should not be used to differentiate IBD from IBS - Authors' reply.
    Iacucci M; Cannatelli R; Labarile N; Ghosh S
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):723-724. PubMed ID: 32673606
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply.
    Al-Ani AH; Prentice RE; Rentsch C; Christensen B
    Aliment Pharmacol Ther; 2021 Mar; 53(6):766-767. PubMed ID: 33599326
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: inflammatory bowel disease services during the Covid-19 pandemic.
    Mungmunpuntipantip R; Wiwanitkit V
    Aliment Pharmacol Ther; 2022 Apr; 55(8):1063. PubMed ID: 35362136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.
    Burgueño JF; Abreu MT
    Inflamm Bowel Dis; 2020 Sep; 26(10):e127. PubMed ID: 32619011
    [No Abstract]   [Full Text] [Related]  

  • 16. Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
    Eltabbakh M; Abd Alaty W; Sakr MA; Sherief AF
    Inflamm Bowel Dis; 2021 Apr; 27(5):e66. PubMed ID: 33512507
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic".
    Dai C; Huang YH
    Dig Dis Sci; 2022 Jan; 67(1):348-349. PubMed ID: 33914215
    [No Abstract]   [Full Text] [Related]  

  • 18. Lived experiences of Idiopathic Inflammatory Bowel Disease (IBD) patients and the perceived impact of the COVID-19 pandemic.
    Koliouli F; Issari P; Mitrou A
    J Health Psychol; 2022 May; 27(6):1379-1393. PubMed ID: 34875898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A surgically relevant summary of the addendum to the S3 guidelines of the DGVS on Crohn's disease and ulcerative colitis : Treatment of chronic inflammatory bowel diseases in the COVID-19 pandemic].
    Grunert PC; Dignass A; Kucharzik T; Stallmach A; Sturm A; Schmidt C
    Chirurg; 2021 Jan; 92(1):30-33. PubMed ID: 33320280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: pancreatic involvement in inflammatory bowel disease-authors' reply.
    Massironi S; Viganò C; Danese S
    Aliment Pharmacol Ther; 2022 Jul; 56(2):371. PubMed ID: 35748849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.